Article info
PDFCommentary
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
- Correspondence to Dr Marina Barcena-Varela, Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA; marina.barcena-varela{at}mssm.edu
Citation
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
Publication history
- Received December 17, 2023
- Accepted December 28, 2023
- First published January 9, 2024.
Online issue publication
May 10, 2024
Article Versions
- Previous version (9 January 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.